which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Cervical cancer is considered a preventable disease because it has causative agent called Human Papilloma Virus (HPV). HPV infection was detected in up to 99% of women with squamous cell carcinoma of uterine cervix. Two HPV vaccines are approv­ ed by the U.S...

as a qHPV vaccine and Cervarix (Glaxo-SmithKline, Middlesex, UK) as a bivalent HPV (biHPV) vaccine. Both of these vaccines are effective for HPV subtypes 16 and 18, and Gardasil is effective against the two additional subtypes 6 and 11. The biHPV vaccine was approved for development in 1998, received FDA approval in 2009, and is now licensed in more than 100 countries and approved in more than ...

BACKGROUND Cervical cancer is the greatest cause of age-weighted years of life lost in the developing world. Human papillomavirus (HPV) infection is associated with a high proportion of cervical cancers, and HPV vaccination may help to reduce the incidence of cancer. The aim of the study was to identify barriers, obstacles, and strategies and to analyze key concerns and lessons learned with res...

n engl j med 355;23 www.nejm.org december 7, 2006 2389 to propose that vaccination be compulsory for girls entering sixth grade. Parents who objected would be able to opt out of the requirement under the same provisions that apply to other vaccinations. The bill passed the state senate by an overwhelming margin a week later and awaits consideration by the house. Other states are likely to follo...

Gardasil is a quadrivalent human papillomavirus (HPV4) vaccine that was approved for use by the US Food and Drug Administration in June 2006. HPV4 vaccine is routinely recommended for administration to women in the USA who are 11-12 years old by the Advisory Committee on Immunization Practices. Previous studies suggest HPV4 vaccine administration was associated with autoimmune diseases. As a co...

BACKGROUND Cervix cancer, preventable, continues to be the third most common cancer in women worldwide, especially in lowest income countries. Prophylactic HPV vaccination should help to reduce the morbidity and mortality associated with cervical cancer. The purpose of the study was to describe the results of and key concerns in eight HPV vaccination programs conducted in seven lowest income co...

N 17 OCTOBER 2007 A CATHOLIC SCHOOL board in northern Ontario — the Huron-Superior Catholic District School Board (H-SCDSB) — voted 5 to 4 to disallow within their schools the human papillomavirus vaccination programs for grade 8 girls that were being led by local public health units. As this was the only school board in On-tario to disallow the program (other school boards had close votes), th...

BACKGROUND Cervical cancer is the third most common cancer in women worldwide, with high incidence in lowest income countries. Vaccination against Human Papilloma Virus (HPV) may help to reduce the incidence of cervical cancer. The aim of the study was to analyze HPV vaccination programs performance implemented in low and middle-income countries. METHODS The Gardasil Access Program provides H...

Chemoprevention agents are an emerging new scientific area that holds out the promise of delaying or avoiding a number of common cancers. These new agents face significant scientific, regulatory, and economic barriers, however, which have limited investment in their research and development (R&D). These barriers include above-average clinical trial scales, lengthy time frames between discovery ...